TAKE CARE OF YOU AND YOUR PRACTICE DURING THIS PANDEMIC. WE ARE HERE TO HELP!

copd

Wellness Vapes
July 14, 2022

‘Wellness’ vapes are all the rage. But are they healthy or just hype?

A new trend is emerging in the vaping world, one that promises big health benefits. Known as “wellness vapes”, they contain vitamins or other supplements instead of nicotine and tout claims of boosted energy, increased immunity and a better night’s sleep. Wellness vapes or “nutritional supplement diffusers” – which allow users to inhale ingredients such…

Wellness Vapes
COPD Sleep
June 22, 2022

Bad Sleep May Be Bad News for People With COPD

If you have COPD, new research suggests you might want to pay close attention to getting good sleep. Poor slumber significantly increased the risk of life-threatening flare-ups of breathing problems in people with incurable, progressive lung disease, investigators reported. “Among those who already have COPD, knowing how they sleep at night will tell me much more…

COPD Sleep
Seasonal Allergies
May 26, 2022

Seasonal Allergies and COPD: Tips to Avoid Complications

Seasonal allergies are a nuisance for most people. For people with COPD, however, any extra condition that makes breathing difficult is automatically more serious. According to a 2012 study at the Johns Hopkins Allergy and Asthma Center, people who had COPD and seasonal allergies experienced worsened respiratory symptoms such as coughing and wheezing. They were also significantly…

Seasonal Allergies
COPD Pesticides
April 28, 2022

Greater On-the-job Exposure to Pesticides Linked to Higher COPD Risk

Being exposed to pesticides at work increases the risk of developing chronic obstructive pulmonary disease (COPD), a large U.K.-based study has found. This was true regardless of whether people smoked or had asthma; smoking and asthma are both known risk factors for COPD. “Focused preventive strategies for workers exposed to pesticides can prevent the associated COPD burden,”…

COPD Pesticides
FDA Approves Symbicort
March 17, 2022

FDA Approves First Generic of Symbicort to Treat Asthma and COPD

Agency Supports Development of Complex Generic Drug-Device Combination Product to Improve Competition and Access to More Affordable Medicine This week, the U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of two common pulmonary health conditions: asthma in patients six years of age…

FDA Approves Symbicort
COPD Heart Failure
February 16, 2022

Study Finds Differences in Patients With Both COPD, Heart Failure

Patients with both heart failure (HF) and chronic obstructive pulmonary disease (COPD) face a unique set of challenges and impairments compared with those with just one of the diseases, according to a new report. The study, published in Scientific Reports, offers new insights to help physicians better treat patients with overlapping conditions. Corresponding author Audrey Borghi-Silva, PhD, MSc, of the…

COPD Heart Failure
Iron COPD
January 19, 2022

Study: Excess Iron Linked with COPD Exacerbation

Evidence suggests higher levels of iron in pulmonary macrophages heightens the risk of infectious exacerbations. A new report yielded fresh insights into the role of pulmonary iron in chronic obstructive pulmonary disease (COPD), suggesting that excess iron in pulmonary macrophages may increase the risk of recurrent airway infection. Writing in the journal Respiratory Research, corresponding author…

Iron COPD
Rome Proposal
January 05, 2022

‘Rome Proposal’ Sets Framework for Classifying COPD Exacerbations

An international team of researchers has published a new framework, dubbed the Rome proposal, for defining and classifying exacerbations of chronic obstructive pulmonary disease (COPD). “The ‘Rome Proposal’ represents an important milestone for better understanding and treating a very important and troubling component of COPD progression and, the prospect for more accurate treatment and better…

Rome Proposal